Go Pro
OTCMKTS:ERBA

ERBA Diagnostics (ERBA) Stock Price, News & Analysis

ERBA Diagnostics logo
$0.04 0.00 (0.00%)
As of 08/27/2020

About ERBA Diagnostics Stock (OTCMKTS:ERBA)

Key Stats

Today's Range
$0.04
$0.04
50-Day Range
$0.04
$0.04
52-Week Range
$0.01
$0.31
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

ERBA Diagnostics (OTCMKTS:ERBA) is a global provider of in vitro diagnostic solutions, offering a comprehensive portfolio of clinical laboratory instruments, reagents and software. The company’s product suite is designed to support clinical chemistry, immunodiagnostics, haematology and molecular diagnostics testing, enabling healthcare providers to deliver accurate and timely results for patient diagnosis and monitoring.

The company’s core offerings include fully automated chemistry analyzers, ELISA and chemiluminescence immunoassay systems, haematology analyzers and molecular testing platforms. ERBA Diagnostics also supplies a broad range of reagents and quality control materials, as well as laboratory information management systems (LIMS) that streamline workflow and data integration in diagnostic laboratories.

ERBA Diagnostics serves a network of distributors and end users across multiple regions, with a presence in Asia, Eastern Europe, Latin America, the Middle East and Africa. By leveraging its global footprint, the company delivers localized sales, technical support and training services to hospitals, reference laboratories and independent testing facilities.

Part of the ErbaMannheim Group, ERBA Diagnostics combines over three decades of industry experience with ongoing investment in research and development. The company places a strong emphasis on regulatory compliance and quality assurance, maintaining certifications and adhering to international standards to support the needs of clinical laboratories worldwide.

AI Generated. May Contain Errors.

Receive ERBA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ERBA Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ERBA Stock News Headlines

ERBA Diagnostics Stock Price History
ERBA Diagnostics (ERBA)
China Declares War
China controls more than 90 percent of the world's refined rare earths and is quietly building a yuan-based payment network, gold vaults in Hong Kong, and cross-border trade deals designed to bypass the dollar. Meanwhile, a 13-nation pact signed inside the State Department and a flurry of executive orders suggest Trump may be resetting the dollar's foundation entirely, what analyst Porter Stansberry calls the Silicon Dollar, anchored to minerals, energy and AI infrastructure. The last dollar reset minted over a thousand new millionaires a day.tc pixel
Decision Diagnostics Corp DECN
See More Headlines

ERBA Stock Analysis - Frequently Asked Questions

ERBA Diagnostics' stock was trading at $0.0350 at the beginning of 2026. Since then, ERBA shares have increased by 0.0% and is now trading at $0.0350.

Shares of ERBA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ERBA Diagnostics investors own include EKF Diagnostics (EKF), Cannabis Wheaton Income (CBWTF), Catalyst Pharmaceuticals (CPRX), ImmunoGen (IMGN), iQIYI (IQ) and Myriad Genetics (MYGN).

Company Calendar

Today
8/20/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
OTCMKTS:ERBA
Previous Symbol
NYSEMKT:ERB
CIK
1095858
Employees
134
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (OTCMKTS:ERBA) was last updated on 8/20/2026 by MarketBeat.com Staff.
From Our Partners